insights_auto
Why is AIM down 3.03%?
Dive Deeperchevron_right
AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.16
arrow_downward
-3.03%(-0.0051) 1D
$0.16
arrow_downward
-0.25% (-0.00040)bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
6.43M
Avg. vol.
2.37M
Volume
503.89K
52-wk high
$2.88
52-wk low
$0.16
EPS
-$3.93
Beta
1.27
Shares outstanding
39.90M
No. of employees
20
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
6.43M
Avg. vol.
2.37M
Volume
503.89K
52-wk high
$2.88
52-wk low
$0.16
EPS
-$3.93
Beta
1.27
Shares outstanding
39.90M
No. of employees
20
News stories
From web sources and news partners
BigGo Finance
·
25 minutes ago
Dow Falls 36 Points for Second Straight Session as Oil Rally Weighs, AI-Related Buying Provides Support
Bloomberg
·
1 hour ago
US Stock Futures Edge Higher After Chipmaker Rally: Markets Wrap
TradingView
·
1 hour ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com